Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Robert Desantis sold 188 shares of the company's stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Robert Desantis also recently made the following trade(s):
- On Friday, October 25th, Robert Desantis sold 1,012 shares of Intuitive Surgical stock. The shares were sold at an average price of $514.00, for a total value of $520,168.00.
- On Tuesday, September 10th, Robert Desantis sold 238 shares of Intuitive Surgical stock. The shares were sold at an average price of $477.50, for a total value of $113,645.00.
- On Thursday, August 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The shares were sold at an average price of $482.21, for a total value of $90,655.48.
- On Monday, August 26th, Robert Desantis sold 396 shares of Intuitive Surgical stock. The shares were sold at an average price of $486.88, for a total value of $192,804.48.
- On Monday, August 12th, Robert Desantis sold 240 shares of Intuitive Surgical stock. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40.
Intuitive Surgical Trading Up 1.1 %
The real reason Elon is fully endorsing Trump
From Porter & Company | Ad
Elon Musk is one of mankind’s greatest innovators.
But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk.
This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
Watch this new documentary and you’ll discover what Elon knows,
NASDAQ ISRG opened at $516.31 on Wednesday. The stock has a 50-day moving average of $489.22 and a 200-day moving average of $444.82. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $523.34. The firm has a market cap of $183.90 billion, a PE ratio of 83.01, a price-to-earnings-growth ratio of 5.11 and a beta of 1.39.
Institutional Investors Weigh In On Intuitive Surgical
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Ullmann Wealth Partners Group LLC raised its holdings in Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider's stock valued at $653,000 after buying an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC raised its holdings in Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider's stock valued at $310,000 after buying an additional 23 shares during the last quarter. Daymark Wealth Partners LLC raised its holdings in Intuitive Surgical by 0.3% during the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider's stock valued at $3,452,000 after buying an additional 24 shares during the last quarter. Indiana Trust & Investment Management CO raised its holdings in Intuitive Surgical by 5.3% during the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider's stock valued at $222,000 after buying an additional 25 shares during the last quarter. Finally, Hoxton Planning & Management LLC raised its holdings in Intuitive Surgical by 4.9% during the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider's stock valued at $238,000 after buying an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on ISRG. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley boosted their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an "equal weight" rating in a report on Monday, July 15th. Evercore ISI reaffirmed a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a report on Thursday, October 17th. Finally, Raymond James upped their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a report on Monday, October 14th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $513.74.
View Our Latest Research Report on ISRG
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
